Barclays’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Buy |
976,988
+191,158
| +24% | +$2.21M | ﹤0.01% | 1088 |
|
|
2025
Q1 | $6.86M | Sell |
785,830
-5,127
| -0.6% | -$44.8K | ﹤0.01% | 1233 |
|
|
2024
Q4 | $11.4M | Buy |
790,957
+188,421
| +31% | +$2.71M | ﹤0.01% | 1052 |
|
|
2024
Q3 | $13.6M | Buy |
602,536
+80,579
| +15% | +$1.82M | ﹤0.01% | 881 |
|
|
2024
Q2 | $10.2M | Buy |
521,957
+464,221
| +804% | +$9.03M | ﹤0.01% | 902 |
|
|
2024
Q1 | $2.17M | Sell |
57,736
-208,562
| -78% | -$7.82M | ﹤0.01% | 1881 |
|
|
2023
Q4 | $14.9M | Buy |
266,298
+244,099
| +1,100% | +$13.7M | 0.01% | 843 |
|
|
2023
Q3 | $916K | Buy |
22,199
+584
| +3% | +$24.1K | ﹤0.01% | 2145 |
|
|
2023
Q2 | $1.21M | Buy |
21,615
+9,970
| +86% | +$557K | ﹤0.01% | 2035 |
|
|
2023
Q1 | $649K | Sell |
11,645
-160,027
| -93% | -$8.92M | ﹤0.01% | 2455 |
|
|
2022
Q4 | $6.26M | Buy |
171,672
+145,505
| +556% | +$5.3M | ﹤0.01% | 1000 |
|
|
2022
Q3 | $745K | Buy |
26,167
+3,815
| +17% | +$109K | ﹤0.01% | 2328 |
|
|
2022
Q2 | $1.01M | Sell |
22,352
-18,061
| -45% | -$817K | ﹤0.01% | 2054 |
|
|
2022
Q1 | $3.07M | Buy |
+40,413
| New | +$3.07M | ﹤0.01% | 1461 |
|